<DOC>
	<DOCNO>NCT00796250</DOCNO>
	<brief_summary>This double-blind , double-dummy , prednisolone-controlled , multi-center , randomize , parallel-group clinical study evaluate therapeutic efficacy repeat infliximab infusion order maintain Crohn 's disease remission end study .</brief_summary>
	<brief_title>Efficacy Infliximab Treatment Patients Affected Corticodependent Crohn 's Disease ( P02732 )</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Male Female patient age 18 65 year . Patients suffer corticodependent Crohn 's disease , reheightening phase , CDAI value &gt; =220 . Patients able participate comply study . Patients adequate bone marrow stock : GB &gt; =3.5x109/L , PLTs &gt; =100 x 103 , Hb &gt; =9 gr/dL . Patients able willing give write informed consent . Patients abscesses active perianal disease . Clinically symptomatic and/or retrodilatation intestinal stenosis . Patients previously treat infliximab . Patients history allergy murine protein . Treatment immunosuppressant AZA , 6mercaptopurine , methotrexate cyclosporine A previous 3 month . Positive feces exams intestinal pathogen , parasitic toxin clostridium difficilis . Tuberculosis ( TBC ) active inactive , evaluate mean detailed description ( personal history tuberculosis possible previous contact source TBC infection ) , appropriate screening test , Thorax Rx , tuberculin test . Presence severe infection hepatitis , pneumonia , pyelonephritis within past 3 month enrolment . Less severe infection , charge upper respiratory tract ( cold syndrome ) , consider exclusion criterion well uncomplicated urinary tract infection , contract previous 3 month study inclusion . Ongoing infection due CMV , pneumocystis carinii , atypical mycobacterium . Proved HIV infection , presence ARC AIDS . Necessity study elective emergency surgical operation . Altered hepatic function : total bilirubin &gt; =1.5 time upper limit normal range ( UNL ) , AST ( SGOT ) &gt; =2 UNL , phosphatase alkaline &gt; =2.5 UNL , PTT INR &gt; =1.5 UNL . Altered renal function : creatinine &gt; =1.5 mg . Presence serious concomitant illness ( cardiac , pulmonary , neurological disease ) . History pathology charge haemopoietic system lymphoproliferative disease lymphoma , lymphadenopathy unusual localisation ( i.e . nape , epitochlear periaortic ) splenomegaly . Presence neoplastic preneoplastic lesion , history neoplasm past 5 year . Presence history drug alcohol abuse . Pregnant lactating woman . Women childbearing potential without adequate contraception except case surgical menopause . These method birth control also use 6 month last infusion . Contraindications AZA ( i.e . lymphoproliferative disease , leukopenia ) prednisolone ( i.e . peptic ulcer , systemic fungal infection ) lay summary product characteristic . Hyperamylasemia &gt; =1.5 time upper limit normal range .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>